Delivery Order SPE2DB24D2011-SPE2DB25FBRQK
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,041.42 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/mL SureClick auto-injectors. This competitively awarded, firm fixed-price delivery order was issued on July 29, 2025, with an ultimate completion date of July 30, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $11,573.95 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors. This firm fixed-price delivery order, issued on September 12, 2025, with an ultimate completion date of September 15, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded without set-aside designation. AmerisourceBergen, a major...
- The Defense Logistics Agency awarded a $24,935.10 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The place of performance is the contractor's corporate office in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,162.07 to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This firm fixed-price delivery order, with an ultimate completion date of August 22, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $7,958.07 to supply Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of August 18, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors, with a ceiling value of $1,388.56. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's corporate office location in Conshohocken, Pennsylvania, and is scheduled for completion by July 28, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,126.53 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injector pharmaceutical products. This firm fixed price delivery order, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a competitively awarded, non-set-aside contract. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. As a child delivery order, this award falls...
- The Defense Logistics Agency awarded a $4,803.48 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. The contract is a firm fixed price delivery order with an ultimate completion date of July 31, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting the contractor's established capability...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injector medication. This firm fixed-price delivery order, valued at $6,244.23, represents a non-competitive child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), a $1 billion agreement running through December 2026. The order will be fulfilled from the...
- The Defense Logistics Agency awarded a $44,398.54 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors. This competitive, firm fixed-price contract was executed on August 20, 2025, with an ultimate completion date of August 21, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- SPE2DB24D2011Indefinite Delivery Contract
- SPE2DB24D2011-SPE2DB25FBRQKDelivery Order
The Defense Logistics Agency awarded a $41,766.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract, which is a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX, valued at $999,999,999.00 through December 2026), carries an ultimate completion date of August 22, 2025. This award was competitively granted with no set-aside designation, and performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, serves as a prime contractor for the Defense Logistics Agency's medical supply chain operations. The company's Indefinite Delivery Contract with DLA Troop Support Medical functions as a comprehensive global pharmaceutical support vehicle enabling the delivery of a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. This specific delivery order for Repatha, a PCSK9 inhibitor used in cardiovascular disease management, exemplifies the company's role in providing specialized pharmaceutical products to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $41.8k | 8/21/25 |